Baron, Ralf <br/><br/>
Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study.  [electronic resource] 

 -  Pain practice : the official journal of World Institute of Pain  06 2016 
 - 580-99 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1533-2500 
<br/><br/><label>Standard No.: </label>10.1111/papr.12308  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analgesics, Opioid--administration & dosage<br/>Delayed-Action Preparations<br/>Endpoint Determination<br/>Female<br/>Humans<br/>Low Back Pain--drug therapy<br/>Male<br/>Middle Aged<br/>Naloxone--administration & dosage<br/>Narcotic Antagonists--administration & dosage<br/>Neuralgia--drug therapy<br/>Oxycodone--administration & dosage<br/>Pain Measurement<br/>Phenols--administration & dosage<br/>Tapentadol